Literature DB >> 16684672

Antioxidant and anti-inflammatory activities of the plant Andrographis paniculata Nees.

K Sheeja1, P K Shihab, G Kuttan.   

Abstract

In this study, we explored the antioxidant and anti-inflammatory properties of the medicinal herb Andrographis paniculata using in vitro as well as in vivo systems. Methanolic extract of Andrographis paniculata was found to inhibit formation of oxygen derived free radicals such as superoxide (32%) hydroxyl radicals (80%) lipid peroxidation (80%) and nitric oxide (42.8%) in in vitro system. In vivo studies using BALB/c mice models also showed significant inhibition in PMA induced superoxide (32.4%) and nitric oxide (65.3%) formation. Interestingly we also found that, administration of Andrographis paniculata extract produced complete inhibition of carageenan induced inflammation compared with control models.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684672     DOI: 10.1080/08923970600626007

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  20 in total

1.  14-Deoxyandrographolide desensitizes hepatocytes to tumour necrosis factor-alpha-induced apoptosis through calcium-dependent tumour necrosis factor receptor superfamily member 1A release via the NO/cGMP pathway.

Authors:  D N Roy; S Mandal; G Sen; S Mukhopadhyay; T Biswas
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Evaluation of anti-inflammatory, analgesic, and antipyretic effects of ethanolic extract of Pedalium murex Linn. fruits.

Authors:  Mahendra K Patel; Divyesh R Mandavia; Tejas K Patel; Manish J Barvaliya; C B Tripathi
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-05-16

Review 3.  Nain-e Havandi Andrographis paniculata present yesterday, absent today: a plenary review on underutilized herb of Iran's pharmaceutical plants.

Authors:  Alireza Valdiani; Mihdzar Abdul Kadir; Soon Guan Tan; Daryush Talei; Mohd Puad Abdullah; Sonia Nikzad
Journal:  Mol Biol Rep       Date:  2011-12-24       Impact factor: 2.316

4.  The genome of the medicinal plant Andrographis paniculata provides insight into the biosynthesis of the bioactive diterpenoid neoandrographolide.

Authors:  Wei Sun; Liang Leng; Qinggang Yin; MeiMei Xu; Mingkun Huang; Zhichao Xu; Yujun Zhang; Hui Yao; Caixia Wang; Chao Xiong; Sha Chen; Chunhong Jiang; Ning Xie; Xilong Zheng; Ying Wang; Chi Song; Reuben J Peters; Shilin Chen
Journal:  Plant J       Date:  2019-01-02       Impact factor: 6.417

5.  A polysaccharide from Andrographis paniculata induces mitochondrial-mediated apoptosis in human hepatoma cell line (HepG2).

Authors:  Yanmei Zou; Hua Xiong; Huihua Xiong; Tao Lu; Feng Zhu; Zhiyong Luo; Xianglin Yuan; Yihua Wang
Journal:  Tumour Biol       Date:  2015-02-05

6.  Development of Synergy-Based Combination of Methanolic Extract of Andrographis paniculata and Berberis aristata Against E. coli and S. aureus.

Authors:  Sageer Abass; Sultan Zahiruddin; Asghar Ali; Mohammad Irfan; Bisma Jan; Qazi Mohd Rizwanul Haq; Syed Akhtar Husain; Sayeed Ahmad
Journal:  Curr Microbiol       Date:  2022-06-15       Impact factor: 2.188

7.  Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian).

Authors:  Wen-Wan Chao; Bi-Fong Lin
Journal:  Chin Med       Date:  2010-05-13       Impact factor: 5.455

8.  An overview of the evidence and mechanisms of herb-drug interactions.

Authors:  Pius S Fasinu; Patrick J Bouic; Bernd Rosenkranz
Journal:  Front Pharmacol       Date:  2012-04-30       Impact factor: 5.810

9.  Cardiovascular activity of labdane diterpenes from Andrographis paniculata in isolated rat hearts.

Authors:  Khalijah Awang; Nor Hayati Abdullah; A Hamid A Hadi; Yew Su Fong
Journal:  J Biomed Biotechnol       Date:  2012-03-28

10.  AP-1/IRF-3 Targeted Anti-Inflammatory Activity of Andrographolide Isolated from Andrographis paniculata.

Authors:  Ting Shen; Woo Seok Yang; Young-Su Yi; Gi-Ho Sung; Man Hee Rhee; Haryoung Poo; Mi-Yeon Kim; Kyung-Woon Kim; Jong Heon Kim; Jae Youl Cho
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-06       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.